Pathological presentation of cardiac mitochondria in a rat model for chronic kidney disease

Abstract

BackgroundMitochondria hold crucial importance in organs with high energy demand especially the heart. We investigated whether chronic kidney disease (CKD), which eventually culminates in cardiorenal syndrome, could affect cardiac mitochondria and assessed the potential involvement of angiotensin II (AngII) in the process.MethodsMale Lewis rats underwent 5/6 nephrectomy allowing CKD development for eight months or for eleven weeks. Short-term CKD rats were administered with AngII receptor blocker (ARB). Cardiac function was assessed by echocardiography and cardiac sections were evaluated for interstitial fibrosis and cardiomyocytes’ hypertrophy. Electron microscopy was used to explore the spatial organization of the cardiomyocytes. Expression levels of mitochondrial content and activity markers were tested in order to delineate the underlying mechanisms for mitochondrial pathology in the CKD setting with or without ARB administration.ResultsCKD per-se resulted in induced cardiac interstitial fibrosis and cardiomyocytes’ hypertrophy combined with a marked disruption of the mitochondrial structure. Moreover, CKD led to enhanced cytochrome C leakage to the cytosol and to enhanced PARP-1 cleavage which are associated with cellular apoptosis. ARB treatment did not improve kidney function but markedly reduced left ventricular mass, cardiomyocytes’ hypertrophy and interstitial fibrosis. Interestingly, ARB administration improved the spatial organization of cardiac mitochondria and reduced their increased volume compared to untreated CKD animals. Nevertheless, ARB did not improve mitochondrial content, mitochondrial biogenesis or the respiratory enzyme activity. ARB mildly upregulated protein levels of mitochondrial fusion-related proteins.ConclusionsCKD results in cardiac pathological changes combined with mitochondrial damage and elevated apoptotic markers. We anticipate that the increased mitochondrial volume mainly represents mitochondrial swelling that occurs during the pathological process of cardiac hypertrophy. Chronic administration of ARB may improve the pathological appearance of the heart. Further recognition of the molecular pathways leading to mitochondrial insult and appropriate intervention is of crucial importance.

Impact of Intravenous Iron on Oxidative Stress and Mitochondrial Function in Experimental Chronic Kidney Disease

“…Most studies on the impact of iv iron are limited to acute systemic oxidative effects, disregarding their longer-term impact and benefits. Despite the central role of mitochondria (within the kidney) in the possible initiation and progression of CKD [18,19,20] and the integral role of iron in key mitochondrial proteins (aconitase, complex I, II or III), the impact of parenteral iv iron therapy as employed in clinical practice on mitochondrial function, oxidative stress and CKD progression has not been sufficiently characterised.…”

Omega-3 Fatty Acids Upregulate SIRT1/3, Activate PGC-1α via Deacetylation, and Induce Nrf1 Production in 5/6 Nephrectomy Rat Model

“…Mar. Drugs 2021, 19, x FOR PEER REVIEW 2 of 10 mitochondrial biogenesis are related to cardiovascular disease [8,9]. Improving mitochondrial biogenesis may be beneficial for cardioprotection in CKD.…”

“…Although mitochondrial biogenesis may link to pathogenesis of mitochondrial dysfunction in non-diabetic chronic kidney disease (CKD), research on this topic is also very limited. CKD and mitochondrial biogenesis are related to cardiovascular disease [ 8 , 9 ]. Improving mitochondrial biogenesis may be beneficial for cardioprotection in CKD.…”

Oxidative stress and inflammation in the development of cardiovascular disease and contrast induced nephropathy

“…Mitochondrial dysfunction is also responsible for reduction in ATP synthesis, and will add to the cellular apoptotic state [ Figure 1]. Interestingly, it has been recently reported that CKD in a rat model can influence cardiac pathologies by changing the function of cardiac tissue and inducing mitochondrial swelling and damage [90] .…”